ICU医疗2月28日盘中股价大跌5.25%,引发市场广泛关注。这家专注于输液治疗领域的公司近期业绩表现欠佳,投资者对公司前景产生担忧。
数据显示,ICU医疗最新季报中净利润为负,每股亏损1.35美元,令人失望。毛利率水平也较低,仅占营收的35%。分析人士指出,公司可能面临着严峻的成本压力。
不过,业内多家机构仍对ICU医疗持看好态度。在5家评级机构中,有4家给予买入评级,认为公司长期发展前景依然光明。但眼下ICU医疗要突破经营困境,仍需努力。公司需要优化产品结构、提高运营效率,才能重拾盈利增长之路。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.